Back
G1 Therapeutics Stock Predictions
Sponsored
GTHX
Sponsored
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
GTHX
G1 Therapeutics
Last Price:
7.16
Seasonality Move:
-14.81%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pmG1 Therapeutics Stock Forecast
- Over the next 52 weeks, G1 Therapeutics has on average historically risen by 42.7% based on the past 7 years of stock performance.
- G1 Therapeutics has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is G1 Therapeutics Stock Undervalued?
The current G1 Therapeutics [GTHX] share price is $7.15. The Score for GTHX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal. - GTHX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will G1 Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, G1 Therapeutics has on average historically risen by 42.7% based on the past 7 years of stock performance.
G1 Therapeutics Stock Rating
Sell
46
G1 Therapeutics (GTHX)
is a Sell
Is G1 Therapeutics overpriced?
- G1 Therapeutics has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
G1 Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
g1therapeutics.com
52-Week Data
52-Week High:
7.19
52-Week Low:
1.08
Prediction Charts
Market Cap:
377.22M
Price in USD:
7.15
Volume:
0
Beta:
1.80
Technical Analysis
SMA50:
5.75
SMA100:
4.60
SMA200:
4.06
52-Wk Change:
379.87%
Stock Predictions
-
Is G1 Therapeutics stock public?
Yes, G1 Therapeutics is a publicly traded company. -
What is the G1 Therapeutics stock quote today?
The G1 Therapeutics stock price is 7.15 USD today. -
How to buy G1 Therapeutics stock online?
You can buy G1 Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-29 | 7.12 | 7.11 | 7.12 | 7.11 |
Aug-30 | 7.11 | 7.12 | 7.12 | 7.11 |
Sep-3 | 7.12 | 7.09 | 7.12 | 7.09 |
Sep-4 | 7.10 | 7.13 | 7.13 | 7.09 |
Sep-5 | 7.12 | 7.13 | 7.13 | 7.12 |
Sep-6 | 7.13 | 7.13 | 7.13 | 7.12 |
Sep-9 | 7.13 | 7.14 | 7.14 | 7.12 |
Sep-10 | 7.13 | 7.13 | 7.14 | 7.12 |
Sep-11 | 7.13 | 7.12 | 7.13 | 7.12 |
Sep-12 | 7.13 | 7.13 | 7.13 | 7.12 |
Sep-13 | 7.13 | 7.15 | 7.15 | 7.13 |
Sep-16 | 7.14 | 7.15 | 7.15 | 7.13 |
Sep-17 | 7.15 | 7.15 | 7.16 | 7.14 |
Sep-18 | 7.15 | 7.15 | 7.15 | 7.15 |
G1 Therapeutics Earnings
G1 Therapeutics Earnings Report: Per Share G1 Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
G1 Therapeutics Forecast Revenue Growth
G1 Therapeutics Stock Analysis: Historical quarterly revenues per share for G1 Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.08 per share, an increase this year of $0.54 per share, and an increase next year of $0.40 per share.
* G1 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.